Literature DB >> 6371224

Frontal lobe dysfunctions in schizophrenia--II. Impairments of psychological and brain functions.

S Levin.   

Abstract

In Part I of this paper (Levin, 1984), it was proposed that the phenomena of eye movement impairments in schizophrenia are consistent with a dysfunction of frontal eye field mechanisms of ocular-motor control. In Part II, a frontal lobe dysfunction in schizophrenia is also proposed on the basis of clinical, psychological, neurochemical, and neuropathological grounds. There are striking similarities between the clinical frontal syndrome and negative symptom schizophrenia. Parallels between experimental studies of disturbances in attention and information processing, in humans and animals with frontal lobe lesions on the one hand, and in schizophrenics on the other, are noteworthy. The evidence for seemingly disparate dysfunctions in schizophrenia of eye movements, psychomotility, cognition, arousal, motivation and affect, is consistent with a disruption of frontal lobe mechanisms of stimulus-response and drive-response modulation. Studies on the neurochemistry and neuroanatomy of schizophrenia provide further evidence for a frontal lobe dysfunction in a subgroup of schizophrenic patients, particularly those with negative symptoms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6371224     DOI: 10.1016/0022-3956(84)90047-5

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  14 in total

Review 1.  [One decade of functional imaging in schizophrenia research. From visualisation of basic information processing steps to molecular-genetic oriented imaging].

Authors:  H Tost; A Meyer-Lindenberg; M Ruf; T Demirakça; O Grimm; F A Henn; G Ende
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

2.  Reduced frontal asymmetry of delta waves during all-night sleep in schizophrenia.

Authors:  Masanori Sekimoto; Masaaki Kato; Tsuyoshi Watanabe; Naofumi Kajimura; Kiyohisa Takahashi
Journal:  Schizophr Bull       Date:  2006-12-16       Impact factor: 9.306

Review 3.  Converging effects of diverse treatment modalities on frontal cortex in schizophrenia: A review of longitudinal functional magnetic resonance imaging studies.

Authors:  Ayse Sakalli Kani; Ann K Shinn; Kathryn E Lewandowski; Dost Öngür
Journal:  J Psychiatr Res       Date:  2016-10-19       Impact factor: 4.791

4.  Reading in schizophrenic subjects and their nonsymptomatic first-degree relatives.

Authors:  Eryl O Roberts; Frank A Proudlock; Kate Martin; Michael A Reveley; Mohammed Al-Uzri; Irene Gottlob
Journal:  Schizophr Bull       Date:  2012-01-20       Impact factor: 9.306

5.  Frontal lobe alterations in schizophrenia: neuroimaging and neuropsychological findings.

Authors:  Juan Carlos Sanz de la Torre; Maite Barrios; Carme Junqué
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-22       Impact factor: 5.270

6.  Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients.

Authors:  R C Arora; H Y Meltzer
Journal:  J Neural Transm Gen Sect       Date:  1991

7.  Changes in cortical thickness in the frontal lobes in schizophrenia are a result of thinning of pyramidal cell layers.

Authors:  M R Williams; R Chaudhry; S Perera; R K B Pearce; S R Hirsch; O Ansorge; M Thom; M Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-19       Impact factor: 5.270

8.  Predictive pursuit association with deficits in working memory in psychosis.

Authors:  Amanda F Moates; Elena I Ivleva; Hugh B O'Neill; Nithin Krishna; C Munro Cullum; Gunvant K Thaker; Carol A Tamminga
Journal:  Biol Psychiatry       Date:  2012-05-02       Impact factor: 13.382

9.  SPEM dysfunction and general schizotypy as measured by the SSQ: a controlled study.

Authors:  Dirk van Kampen; Jan Berend Deijen
Journal:  BMC Neurol       Date:  2009-06-29       Impact factor: 2.474

Review 10.  [Frontal lobe hypoactivity in schizophrenia: change in perspective].

Authors:  L Laplante; J Everett
Journal:  J Psychiatry Neurosci       Date:  1992-11       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.